Baker Bros. Advisors LP

Filing Details

13F-HR • 2025-03-31
SEC
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
89
Total Value
9036702464
Accession Number
0001104659-25-049518
Form Type
13F-HR
CIK
0001263508
Manager Name
Baker Bros. Advisors LP
Data Enrichment
94% identified
84 identified5 unidentified

Holdings

89 positions
Manager:
SEC
Search and click to pin securities to the top
Page 4 of 5
Celldex Therapeutics, Inc.
CLDX|15117B202
Shares:
247644(+0.0%)
Value:
$4.5B(-28.2%)
829401108
829401108
Shares:
400000
Value:
$4.2B
BioNTech SE
BNTX|09075V102
Shares:
45031(+0.0%)
Value:
$4.1B(-20.1%)
TScan Therapeutics, Inc.
TCRX|89854M101
Shares:
2784792(+0.0%)
Value:
$3.8B(-54.6%)
Disc Medicine, Inc.
IRON|254604101
Shares:
77050(+0.0%)
Value:
$3.8B(-21.7%)
Vir Biotechnology, Inc.
VIR|92764N102
Shares:
542539(-50.0%)
Value:
$3.5B(-55.8%)
Sana Biotechnology, Inc.
SANA|799566104
Shares:
2030949(-14.7%)
Value:
$3.4B(-12.1%)
Sagimet Biosciences Inc.
SGMT|786700104
Shares:
952996(+0.0%)
Value:
$3.1B(-27.6%)
Relay Therapeutics, Inc.
RLAY|75943R102
Shares:
1160117(+0.0%)
Value:
$3.0B(-36.4%)
Wave Life Sciences Ltd.
WVE|Y95308105
Shares:
344063(+0.0%)
Value:
$2.8B(-34.7%)
FATE THERAPEUTICS INC
FATE|31189P102
Shares:
3258402(+0.0%)
Value:
$2.6B(-52.1%)
Skye Bioscience, Inc.
SKYE|83086J200
Shares:
1450638(+0.0%)
Value:
$2.3B(-43.8%)
Protara Therapeutics, Inc.
TARA|74365U107
Shares:
536832(+0.0%)
Value:
$2.3B(-19.3%)
Enliven Therapeutics, Inc.
ELVN|29337E102
Shares:
114833(+0.0%)
Value:
$2.3B(-12.5%)
Contineum Therapeutics, Inc.
CTNM|21217B100
Shares:
312500(+0.0%)
Value:
$2.2B(-52.4%)
Prime Medicine, Inc.
PRME|74168J101
Shares:
1028466(+0.0%)
Value:
$2.0B(-31.8%)
Tectonic Therapeutic, Inc.
TECX|878972108
Shares:
100000
Value:
$1.8B
vTv Therapeutics Inc.
VTVT|918385204
Shares:
97314(+0.0%)
Value:
$1.7B(+25.4%)
Compass Therapeutics, Inc.
CMPX|20454B104
Shares:
547498(-64.8%)
Value:
$1.0B(-53.9%)
Neumora Therapeutics, Inc.
NMRA|640979100
Shares:
1034600(+0.0%)
Value:
$1.0B(-90.6%)